Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases of Central Nervous System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06124248
What this trial is testing

Effectiveness of the RISE Intervention

Who this might be right for
Sedentary BehaviourStroke
UMC Utrecht 1,000
Not applicableLooking for participantsNCT05049148
What this trial is testing

Platelets Activation in Brain Neoplasms

Who this might be right for
GliomaBlood PlateletsInflammation+1 more
Fondation Ophtalmologique Adolphe de Rothschild 50
Large-scale testing (Phase 3)Study completedNCT02360215
What this trial is testing

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Who this might be right for
Cognitive ImpairmentMetastatic Malignant Neoplasm in the BrainSolid Neoplasm
NRG Oncology 518
Not applicableStudy completedNCT00970450
What this trial is testing

The Central Analgesic Effects of Paracetamol on Serotonergic Pathways

Who this might be right for
Analgesia
University Hospital, Basel, Switzerland 16
Not applicableUnknownNCT05302479
What this trial is testing

Validating a Modified COMPASS 31questionnaire for Treatment Outcomes

Who this might be right for
Headache, MigrainePersistent Post Traumatic HeadacheCervicogenic Headache
Brooke Army Medical Center 35
Early research (Phase 1)Study completedNCT02228369
What this trial is testing

Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer

Who this might be right for
EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
AstraZeneca 108
Not applicableLooking for participantsNCT04179695
What this trial is testing

Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care

Who this might be right for
Parkinson's Disease
University Hospital, Lille 120
Large-scale testing (Phase 3)UnknownNCT01353573
What this trial is testing

Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm to the Adult Brain
Hamilton Health Sciences Corporation 60
Not applicableLooking for participantsNCT06101069
What this trial is testing

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Who this might be right for
Brain TumorBrain NecrosisBrain Metastases+1 more
Case Comprehensive Cancer Center 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03028337
What this trial is testing

Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases

Who this might be right for
Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT06289023
What this trial is testing

HA-WBRT-SIB for Brain Metastasis of Lung Cancer

Who this might be right for
Lung NeoplasmBrain MetastasesSimultaneous Integrated Boost+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Not applicableStudy completedNCT02419131
What this trial is testing

Cognitive-Behavior Therapy for Posttraumatic Headache

Who this might be right for
Post-traumatic HeadachePTSD
The University of Texas Health Science Center at San Antonio 193
Testing effectiveness (Phase 2)Looking for participantsNCT04923542
What this trial is testing

SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

Who this might be right for
Brain MetastasesHR+ Metastatic Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 31
Not applicableUnknownNCT00398437
What this trial is testing

Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
Jules Bordet Institute 96
Large-scale testing (Phase 3)Not Yet RecruitingNCT07191145
What this trial is testing

Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)

Who this might be right for
Post Traumatic Headache
Sunnybrook Health Sciences Centre 80
Testing effectiveness (Phase 2)Looking for participantsNCT07100600
What this trial is testing

Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

Who this might be right for
HER2-positive Advanced Breast CancerBrain MetastasesRadiotherapy
Henan Cancer Hospital 224
Early research (Phase 1)Study completedNCT05021328
What this trial is testing

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

Who this might be right for
NSCLC
Hubei Cancer Hospital 13
Not applicableStudy completedNCT02810509
What this trial is testing

Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea

Who this might be right for
Atrial FibrillationStroke
Inje University 1,814
Not applicableLooking for participantsNCT07272616
What this trial is testing

Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison

Who this might be right for
Brain Neoplasms
Region Stockholm 100
Early research (Phase 1)Active Not RecruitingNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 159
Next Page